Drugs / gp75 DNA vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00034554 | Mar 2002 → Sep 2004 | melanoma | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp75 DNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00034554 ↗ |
| Modality | Vaccine | “gp75 DNA vaccine” NCT00034554 ↗ |
| Route | Intramuscular | “Injection sites will be given intramuscularly” NCT00034554 ↗ |